Judgment of the General Court (Second Chamber) of 15 September 2015
Judgment of the General Court (Second Chamber) of 15 September 2015.#Novartis Europharm Ltd v European Commission.#Medicinal products for human use — Marketing authorisation for the generic medicinal product Zoledronic acid Teva Pharma — zoledronic acid — Regulatory data protection period for the reference medicinal products Zometa and Aclasta, containing the active substance zoledronic acid — Directive 2001/83/EC — Regulation (EEC) No 2309/93 and Regulation (EC) No 726/2004 — Global marketing authorisation — Regulatory data protection period.#Case T-472/12.
Part of a pack
Available languages and formats
Back to list of results